Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
| Conditions: | Breast Cancer|Colorectal Cancer|Kidney Cancer|Lung Cancer|Malignant Mesothelioma|Pancreatic Cancer |
| Start Date: | April 1, 1991 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00002475 |
| Study Type: | Interventional |
| Intervention: | Biological: allogeneic tumor cell vaccine|Biological: autologous tumor cell vaccine|Biological: recombinant interferon alfa|Biological: recombinant interferon gamma|Biological: sargramostim|Drug: cyclophosphamide |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | St. Vincent Medical Center - Los Angeles |
| Ages: | Adult|Senior |
| Enrollment: | 40 |
| Funded By: | Other |
| First Received: | November 1, 1999 |
| End Date: | |
| Last Updated: | June 11, 2009 |
| Last Verified: | November 1, 2008 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
